The Little Canada-based company develops medical technology, products and services that treat cardiac, neurological and chronic pain patients.
Delayed Price / Updated: /
|52 Week High||71.90|
|52 Week Low||49.94|
|Today's Range||64.68 - 64.42|
Medtronic’s planned acquisition of Covidien, a $43 billion deal that should have shaken the ground plenty hard under the feet of St. Jude Medical’s executives, hasn’t had that much...
Second-quarter profit more than doubled at St. Jude Medical Inc., the result of continued strong demand for its heart-related devices.The Little Canada-based company on Wednesday raised its outlook...
The U.S. government expressed satisfaction with changes at a St. Jude Medical Inc. factory it cited earlier for testing and record-keeping problems, the company said Wednesday, resolving an issue...
A Chinese market for medical technology used to be on the long list of lofty goals for devicemakers like Medtronic. Now U.S. med-tech firms are seeing double-digit growth as they partner with Chinese...
Morningstar analyst Bridget Weishaar wrote in her quarter-ending consumer cyclical report last week “the structural shift to e-commerce from traditional retail reached a critical inflection...
|Current year rank||30|
|Current year compensation||$3,698,451|
|Percent change of the CEO||26.0|
The Little Canada-based company is beginning to enroll U.S. patients in a clinical study of its new spinal cord stimulation system, which delivers what it calls burst stimulation.
Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.